Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

Abstract Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. There is no info...

Full description

Bibliographic Details
Main Authors: Jaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, Boris Afanasyev, Emanuele Angelucci, Fabio Ciceri, Didier Blaise, Jan J. Cornelissen, Ellen Meijer, J. L. Diez-Martin, Yener Koc, Montserrat Rovira, Luca Castagna, Bipin Savani, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Hematology & Oncology
Subjects:
Post-transplant cyclophosphamide
Haploidentical transplant
Alternative donor transplants
Acute leukemia
Allogeneic stem cell transplant
Online Access:http://link.springer.com/article/10.1186/s13045-020-00882-6

Internet

http://link.springer.com/article/10.1186/s13045-020-00882-6

Similar Items